Find High-Impact Pharmacy Savings Opportunities in Your Existing Purchase Data

Get a complimentary Rx Spend Opportunity Assessment

solutions-hero

What Could Your Pharmacy Data Be Telling You?

Pharmacy teams are navigating rising acquisition costs, complex reimbursement dynamics, changing product strategies, and increasing pressure to find savings.

The opportunities may already be visible in your purchasing data — if you know where to look.

Curvo’s pharmacy analytics experts will analyze your organization’s purchase history and provide a customized assessment of potential opportunities across pricing, product selection, reimbursement, and purchasing strategy.

Potential Areas of Analysis

eye-icon-new

PRICING OPPORTUNITY

Identify recent NDC-level price increases, market price parity opportunities, and potential generic equivalent conversions.
pharmacy-icon

BIOSIMILAR OPPORTUNITY

Evaluate biosimilar adoption trends, purchasing behavior, and Medicare Part B reimbursement margins.
list-and-gear

340B OPTIMIZATION

For eligible organizations, identify potential 340B ceiling price verification opportunities, sub-340B purchasing opportunities, and excess WAC spend.
graph-icon

CUSTOM ANALYSIS

Have a specific question? Our pharmacy team can often tailor portions of the assessment around therapeutic classes, manufacturers, contracts, or other purchasing concerns.

How it Works

1. Provide your purchase history.

Most organizations can simply export one year of pharmacy purchasing data directly from their primary wholesaler. Curvo can provide instructions or coordinate with the wholesaler where appropriate.

2. Curvo analyzes your data.

Our pharmacy analytics experts evaluate your purchasing activity across multiple opportunity areas.

3. Review your personalized findings.

We’ll walk your team through the results, highlight potential opportunities, and help identify areas worth further investigation.

See What Opportunities Are Hiding in Your Rx Data

Request Your Assessment

Explore additional insights and resources.